1. What Happened? Kolmar BNH’s Performance Analysis

In the first half of 2025, Kolmar BNH experienced a year-over-year decline in revenue, operating profit, and net income. The economic slowdown and intensifying market competition are cited as primary causes. The decline in average selling prices has directly impacted profitability. Furthermore, the increase in inventory and long-term debt raises concerns about the company’s financial health.

2. Why This Decline? Analyzing the Causes

Is Kolmar BNH’s performance decline a temporary blip or a structural issue? It’s a result of various factors, including increased competition in the health functional foods and cosmetics markets, rising raw material prices, and weakened consumer sentiment. Notably, the lack of core products beyond ‘HemoHIM’ and the uncertain success of new business ventures raise questions about Kolmar BNH’s long-term growth potential.

3. What’s Next? Kolmar BNH’s Future Outlook

Kolmar BNH is focusing on securing new growth engines through business diversification (smart farms, technology research services), and the dividend declaration signals a commitment to shareholder returns. However, short-term profitability improvements are expected to be challenging due to the potential for continued economic slowdown, intensifying competition, and volatility in raw material prices. The success of new businesses and efforts to improve profitability will be crucial for Kolmar BNH’s future stock performance.

4. What Should Investors Do? Investment Strategy Recommendations

Short-term investors should focus on profitability improvement efforts, dividend policy, and managing exchange rate volatility. Long-term investors should consider the success potential of new businesses, strengthening of financial soundness, R&D investment efficiency, and ESG management performance when making investment decisions. Kolmar BNH’s current situation presents both positive and negative aspects, requiring a cautious approach.